Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 04 11 2020
accepted: 10 03 2021
revised: 11 01 2021
pubmed: 20 4 2021
medline: 21 10 2021
entrez: 19 4 2021
Statut: ppublish

Résumé

Value of chest CT was mainly studied in area of high COVID-19 incidence. The aim of this study was therefore to evaluate chest CT performances to diagnose COVID-19 pneumonia with regard to RT-PCR as reference standard in a low incidence area. A survey was sent to radiology department in 4 hospitals in an administrative French region of weak disease prevalence (3.4%). Study design was approved by the local institutional review board and recorded on the clinicaltrial.gov website (NCT04339686). Written informed consent was waived due to retrospective anonymized data collection. Patients who underwent a RT-PCR and a chest CT scan within 48 h for COVID-19 pneumonia suspicion were consecutively included. Diagnostic accuracy including the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of chest CT regarding RT-PCR as reference standard were calculated. One hundred twenty-nine patients had abnormal chest CT findings compatible with a COVID-19 pneumonia (26%, 129/487). Among the 358 negative chest CT findings, 3% (10/358) were RT-PCR positive. Chest CT sensitivity, specificity, positive, and negative predictive value were respectively 87% (IC95: 85, 89; 69/79), 85% (IC95: 83, 87; 348/408), 53% (IC95: 50, 56; 69/129), and 97% (IC95: 95, 99; 348/358). In a low prevalence area, chest CT scan is a good diagnostic tool to rule out COVID-19 infection among symptomatic suspected patients. • In a low prevalence area (3.4% in the administrative area and 5.8% at mean in the study) chest CT sensitivity and specificity for diagnosing COVID-19 pneumonia were 87% and 85% respectively. • In patients with negative chest CT for COVID-19 pneumonia, the negative predictive value of COVID-19 infection was 97% (348/358 subjects). • Performance of CT was equivalent between the 4 centers participating to this study.

Identifiants

pubmed: 33871709
doi: 10.1007/s00330-021-07863-4
pii: 10.1007/s00330-021-07863-4
pmc: PMC8054502
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

8141-8146

Informations de copyright

© 2021. European Society of Radiology.

Références

Jpn J Radiol. 2020 Dec;38(12):1209-1210
pubmed: 32661878
J Thromb Thrombolysis. 2021 Jan;51(1):40-46
pubmed: 32613385
Eur Radiol. 2021 Feb;31(2):795-803
pubmed: 32813105
Radiology. 2021 Feb;298(2):E81-E87
pubmed: 32870139
Eur Radiol. 2020 Aug;30(8):4381-4389
pubmed: 32193638
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353
Eur Respir J. 2020 Jun 25;55(6):
pubmed: 32398302
Eur Radiol. 2020 Dec;30(12):6537-6544
pubmed: 32621241
Eur Radiol. 2021 May;31(5):2819-2824
pubmed: 33051732
New Microbes New Infect. 2020 Sep;37:100750
pubmed: 32874594

Auteurs

Clément Thomas (C)

Radiology Department, University Hospital Centre Poitiers, Poitiers, Vienne, France.
Dactim Mis, LMA, UMR CNRS 7348, Poitiers, Vienne, France.

Mathieu Naudin (M)

Dactim Mis, LMA, UMR CNRS 7348, Poitiers, Vienne, France.

Jean-Pierre Tasu (JP)

Radiology Department, University Hospital Centre Poitiers, Poitiers, Vienne, France.
LaTIM, UMR 1101, INSERM, Bretagne University, Finistère, Brest, France.

Charles Leclerc (C)

Hospital Centre of Royan, Charente-Maritime, Royan, France.

Lucas Depaire (L)

Radiology Department, University Hospital Centre Poitiers, Poitiers, Vienne, France.
Hospital Centre of Angoulême, Charente, Angoulême, France.

Marie Subervillle (M)

Radiology Department, University Hospital Centre Poitiers, Poitiers, Vienne, France.
Hospital Centre of Chatêllerault, Chatêllerault, Vienne, France.

Mathilde Vionnet (M)

Radiology Department, University Hospital Centre Poitiers, Poitiers, Vienne, France.
Hospital Centre of Angoulême, Charente, Angoulême, France.

Rémy Guillevin (R)

Radiology Department, University Hospital Centre Poitiers, Poitiers, Vienne, France.
Dactim Mis, LMA, UMR CNRS 7348, Poitiers, Vienne, France.

Guillaume Herpe (G)

Radiology Department, University Hospital Centre Poitiers, Poitiers, Vienne, France. guillaume.herpe@chu-poitiers.fr.
Dactim Mis, LMA, UMR CNRS 7348, Poitiers, Vienne, France. guillaume.herpe@chu-poitiers.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH